ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Determine Safety, Pharmacokinetics and Pharmacodynamics of Intravenous TKM 080301 in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01262235
Recruitment Status : Completed
First Posted : December 17, 2010
Last Update Posted : August 28, 2015
Sponsor:
Information provided by (Responsible Party):
Arbutus Biopharma Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2015
  Actual Study Completion Date : August 2015